TuHURA Biosciences files debt obligation update with SEC
The pharmaceutical company submitted an 8-K filing covering a debt obligation event.
TuHURA Biosciences, Inc./NV filed an 8-K with the SEC on 2026-08-21 regarding a debt obligation event.[1]
The filing, with accession number 0001193125-26-361272, covers items 2.03 and 9.01 and has a period ending date of 2026-08-20.[1]
TuHURA Biosciences, Inc./NV is incorporated in NV and trades on Nasdaq under the ticker HURA.[2]
The company's SIC description is Pharmaceutical Preparations.[2]
A prior debt obligation filing was submitted by TuHURA Biosciences, Inc./NV on 2026-08-13, with accession number 0001193125-26-349540.[3]